|
|
Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiovascular and non-cardiovascular mortality
A. Shahim
,
M. Hourqueig
,
L. H. Lund
,
G. Savarese
,
E. Oger
et al.
European Journal of Heart Failure, 2021, 23, pp.24-25
Journal articles
hal-03510769v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Do patients with acute heart failure and preserved ejection fraction have heart failure at follow-up, impact of framingham criteria
C. Camilla Hage
,
U. Lofstrom
,
Erwan Donal
,
E. Oger
,
J-C Daubert
et al.
European Journal of Heart Failure, 2017, 19, pp.13--13
Journal articles
hal-01559939v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Serum IGFBP-7 is associated with diastolic dysfunction and predicts outcomes in heart failure and preserved ejection fraction
C. Camilla Hage
,
M. Bjerre
,
J. Frystyk
,
H. Gu
,
K. Brismar
et al.
European Journal of Heart Failure, 2017, 19, pp.478--478
Journal articles
hal-01559936v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction
a I Nagy
,
C Hage
,
B Merkely
,
E Donal
,
J-C Daubert
et al.
Journal articles
hal-01744388v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Galectin-3 in different phenotypes of heart failure
C. Camilla Hage
,
A-C Bergman
,
M. Estonius
,
Erwan Donal
,
C. Linde
et al.
European Journal of Heart Failure, 2016, 18, pp.492--493
Journal articles
hal-01343166v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|